This drug, developed by Eli Lilly, is expected to be the next step in addressing and treating overweight and obesity
Reviewed by Fibia Gee, UGA Dietetic Intern References De Carvalho, C
The Wegovy Injection: In the landmark STEP 1 clinical trial , patients using the 2.4 mg weekly injection lost an average of 14.9% of their body weight over 68 weeks, vs 2.4% with the placebo group
Increased cellular catabolism, heightened endogenous purine synthesis, and a diet rich in purines can elevate urate levels
The prescribing information also says Foundayo may cause fetal harm and should be discontinued when pregnancy is recognized
Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance